Calidi Biotherapeutics, Inc. (CLDI) AMEX

5.97

-0.21(-3.40%)

Updated at August 07 12:55PM

Currency In USD

Valuation

Market Cap9.21M
Enterprise Value6.65M
P/E Ratio-7.35
PEG Ratio-0.12
Price/Sales Ratio0
Price/Book Ratio22.85
Enterprise/Revenue0
Enterprise/EBITDA-0.59

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.43
Return On Equity6.36

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-21.78M
Net Income-22.14M
Diluted EPS-2.97

Balance Sheet

Total Cash10.56M
Total Cash/Share0.39
Total Debt4.71M
Total Debt/Equity0.59
Current Ratio2.12
Book Value Per Share0.27

Price History

52-Week Change-69.88
52-Week High46.68
52-Week Low2.44
Moving Average 50 Days5.45
Moving Average 200 Days11.06

Statistics

Average Volume1.71M
Shares Outstanding2.88M
% Held by Institutions20.15

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateAugust 05, 2025